
Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial
Keywords: مولتیپل میلوما; Low dose dexamethasone; Multiple myeloma; Pomalidomide; Quality of life; Relapsed/Refractory